Dr. Daniel John O'neill M.D.

Recommended Articles

• A Trulia Entrepreneur and His Solution to End Type 2 Diabetes

  Sami Inkinen is a hugely successful entrepreneur who cooperated in the founding and development of Trulia, a real estate empire which was sold in 2014 to Zillow for the staggering amount of $3.5 billion. Using part of his fortune, Inkinen went on to build Virtra, a health care startup whose sole...

• Common Antioxidant May Slow Multiple Sclerosis Progression

  To date, multiple sclerosis (MS), a chronic neurological condition, affects more than 2.3 million individuals worldwide. The immune system mistakenly attacks the myelin, which is the protective layer that surrounds the nerve fibers. This, in turn, disrupts the regular nerve signaling between the...

• Treatments for Binge Eating Disorder

  Binge eating disorder can make a person’s life miserable. Actually, most people feel ashamed to come out and seek treatment. It is an easy condition to hide and someone might keep it from even the people closest to him or her. Eating disorders need a flexible treatment plan that can be adjusted to...

• The Dangers of Lyme disease

  According to the Centers of Disease Control and Prevention (CDC) about 300,000 Americans are infected with Lyme disease every tick season. The tick season is during the spring and summer. The first incidence of Lyme disease was reported in 1975 in Old Lyme, Connecticut.  Lyme disease is the most...

• The Importance of Compassionate Nursing

  Lately, nursing has come under fire for "losing" their compassionate touch when caring for patients. With widespread complaints about negligence in nursing homes, onlookers believe that the job should be revamped. Being compassionate does not require a high skill level. It's more important to be...

• Common Multiple Sclerosis Treatments: An Overview

  A debilitating disease that was once the face of a crushing and “hopeless” diagnosis has evolved from having one effective treatment to multiple effective treatments. Longtime sufferers who didn’t respond to one medication now have options to try others, to participate in a clinical trial or...